使用Ilizarov外固定架进行踝关节融合术是治疗化脓性踝关节炎的有效方法吗?一项至少随访6年的研究
该研究纳入54例化脓性踝关节炎患者,行根治性清创与Ilizarov外固定架初次踝关节融合术,平均随访9±1年。最终骨性融合率达96%(52/54),AOFAS、VAS活动痛、SF-12躯体与心理评分均较术前显著改善(p<0.001)。作者认为该术式或可清除感染并恢复足功能,但患者应充分知晓外固定架相关并发症。
要点
- 初次骨性融合率为94%(51/54),延迟愈合2%(1/54),骨不连6%(3/54),最终融合率96%(52/54)。
- 感染复发率为2%(1/54),术后AOFAS评分中位数从28分改善至80分(p<0.001)。
- VAS活动痛评分中位数从8分降至2分(p<0.001),PCS与MCS评分均显著改善。
核心结论
- 作者认为,使用Ilizarov外固定架行踝关节融合术或可清除化脓性踝关节炎患者的感染并恢复足功能。
- 作者指出,患者应充分知晓外固定架相关并发症,如针道感染、感染复发和骨不连;规范且专业的针道护理很重要。
- 作者建议,未来研究应探索心理支持对接受Ilizarov外固定架踝关节融合术患者的影响。
研究设计与样本
- 2010年4月至2015年3月共治疗59例化脓性踝关节炎患者,其中54例(92%)在至少6年随访时纳入分析。
- 患者平均随访9±1年,61%(33/54)为男性,平均年龄48±12岁;46%(25/54)吸烟,13%(7/54)患2型糖尿病。
- 所有患者接受根治性清创与Ilizarov外固定架初次踝关节融合术,术后予抗生素治疗,并鼓励早期负重行走。
主要发现
- 初次骨性融合率为94%(51/54),延迟愈合率为2%(1/54),骨不连率为6%(3/54);最终骨性融合率为96%(52/54)。
- 感染复发率为2%(1/54)。
- AOFAS评分中位数从术前28分(范围8-59)改善至末次随访80分(范围52-86),中位差值52分(p<0.001)。
- VAS活动痛评分中位数从术前8分(范围6-9)降至末次随访2分(范围0-5),中位差值-6分(p<0.001)。
- SF-12 PCS评分中位数从术前0分(范围0-30)改善至末次随访70分(范围40-95),中位差值70分(p<0.001);MCS评分中位数从术前46分(范围21-75)改善至末次随访75分(范围50-92),中位差值29分(p<0.001)。
关键数值与推荐
- 骨性融合定义为9个月内融合界面出现连续骨小梁和完全皮质桥接;延迟愈合定义为9至12个月实现融合;骨不连定义为12个月时未实现融合。
- 并发症定义为任何偏离预期术后病程的情况。
- AOFAS评分的最小临床重要差异(MCID)为100分中的30分,VAS活动痛评分的MCID为10分中的2分,PCS和MCS评分的MCID分别为7分和9分。
临床怎么用
- 作者认为,对于化脓性踝关节炎患者,使用Ilizarov外固定架行踝关节融合术或可清除感染并恢复足功能。
- 作者指出,患者应充分知晓外固定架相关并发症,如针道感染、感染复发和骨不连。
- 作者强调,规范且专业的针道护理很重要。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Septic ankle arthritis is a devastating clinical problem with a high potential for permanent disability and amputation. Successful treatment of septic ankle arthritis remains a challenge for the surgeon and patient. Ankle arthrodesis combined with radical debridement may be an effective option to eradicate infection and salvage the limb. Although numerous fusion methods have been proposed, there is controversy about the most effective technique. QUESTIONS/PURPOSES: At a minimum follow-up of 6 years after ankle arthrodesis performed using an Ilizarov external fixator, we asked, (1) In what proportion of patients was bony fusion achieved? (2) What complications were observed, and what reoperations were performed in these patients? (3) How much did patient-reported outcomes improve from before surgery to the most recent follow-up in this group? METHODS: Between April 2010 to March 2015, we treated 59 patients for septic ankle arthritis. Of those, we considered patients who were at least 18 years of age with irreversible destruction of the joint as potentially eligible. During that time period, all patients met the prespecified criteria and were treated with ankle arthrodesis using an Ilizarov external fixator. Two percent (one of 59) of patients were excluded because they died in the second year after surgery for reasons unrelated to the procedure, and another 7% (four of 59) of patients were excluded because they were lost before the minimum study follow-up interval of 6 years. Finally, 92% (54 of 59) of patients were analyzed at a mean follow-up time of 9 ± 1 years. A total of 61% (33 of 54) were men, and they had a mean age of 48 ± 12 years. Forty-six percent (25 of 54) of patients were smokers, and 13% (seven of 54) of patients had Type 2 diabetes mellitus. All patients received radical debridement and primary arthrodesis with an Ilizarov external fixator, followed by antibiotic therapy. Postoperatively, patients were instructed to perform lower extremity functional exercises and external fixator care; weightbearing ambulation as tolerated was encouraged as early as possible. Fusion was assessed with a radiographic review that was performed by an individual who was not involved in the surgical care of these patients. We defined bony fusion as continuous trabeculae and complete cortical bridging in the fusion interface achieved before 9 months; delayed union was defined as fusion achieved by 9 to 12 months; and nonunion was defined as patients in whom fusion was not achieved by 12 months. Complications and reoperations were tallied through a record review that was performed by an individual who was not involved in the surgical care of these patients. We defined complications as any deviation from the expected postoperative course. We used the American Orthopedic Foot and Ankle Society (AOFAS) ankle-hindfoot score, the VAS active pain score, and the SF-12 questionnaire (including the physical component summary [PCS] score and mental component summary [MCS] score) to assess patient-reported outcomes. The minimum clinically important difference (MCID) for the AOFAS score was 30 points of 100, the MCID for the VAS active pain score was 2 points of 10, and the MCID of PCS and MCS scores was 7 points and 9 points, respectively. RESULTS: Primary bony fusion was achieved in 94% (51 of 54) of patients. Delayed union was found in 2% (one of 54) of patients. Nonunion was found in 6% (three of 54); one of these patients underwent autologous bone grafting during revision, and bony fusion was ultimately achieved. Final bony fusion was achieved in 96% (52 of 54) of patients. Recurrent infection was found in 2% (one of 54). The median (range) AOFAS score improved from 28 points (8 to 59) before surgery to 80 points (52 to 86) at the most recent follow-up (median difference 52; p < 0.001). The median (range) VAS active pain score decreased from 8 points (6 to 9) before surgery to 2 points (0 to 5) at the most recent follow-up (median difference -6; p < 0.001). For the Short Form 12-item score, the median (range) PCS score improved from 0 points (0 to 30) before surgery to 70 points (40 to 95) at the most recent follow-up (median difference 70; p < 0.001), and the median (range) MCS score improved from 46 points (21 to 75) before surgery to 75 points (50 to 92) at the most recent follow-up (median difference 29; p < 0.001). CONCLUSION: Ankle arthrodesis with Ilizarov external fixation might eradicate an infection and restore foot function in patients with septic ankle arthritis. However, patients should be fully informed of the complications related to the external fixator, such as pin-tract infections, recurrent infection, and nonunion. Standardized and professional pin care is important. Additionally, because Ilizarov external fixators can be inconvenient to the patients' daily lives, future studies should explore how psychologic support affects patients who undergo ankle arthrodesis with these devices. LEVEL OF EVIDENCE: Level IV, therapeutic study.
引用
- Wang S, Li B, Yu X, et al. Is Ankle Arthrodesis With an Ilizarov External Fixator an Effective Treatment for Septic Ankle Arthritis? A Study With a Minimum of 6 Years of Follow-up. Clin Orthop Relat Res. 2022. PMID: 36136051. doi:10.1097/CORR.0000000000002418
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。